- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Medication Adherence as it Relates to Quality of Diabetes Care
Josh Benner, PharmD, ScD, says nonadherence in diabetes medication is a large contributor to high costs in healthcare and should be a priority for care givers.
Josh Benner, PharmD, ScD, says nonadherence in diabetes medication is a large contributor to high costs in healthcare, and should be a priority for care givers. Macrotrends in both policy and practice may change this problem. One such trend is the growing amount of evidence linking adherence to clinical outcomes and costs. That evidence can then work its way into the development of quality measures. Another example of a macrotrend is the drive for meaningful use of electronic health records.
“As frustrated as many of us are that we're not improving adherence widely, the truth is that it's not because we don't know how,” says Dr Benner. “Many people used to think of this as pharma's problem or as patients' problem, but now it's payers problem and it's providers' problem. So we all share responsibility for making this better.”
Consensus-based quality measures, especially in the area of diabetes medication use, will continue to improve adherence rates and reduce costs on the health system.
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
